November 26, 2020

Volume X, Number 331

Advertisement

November 25, 2020

Subscribe to Latest Legal News and Analysis

November 24, 2020

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
18
Sep
Regulating Medical Devices Post Brexit McDermott Will & Emery
18
Sep
Meat Processing: COVID Liabilities Polsinelli PC
18
Sep
The Next in the Series of Executive Orders Affecting the Pharmaceutical Industry Sheppard, Mullin, Richter & Hampton LLP
17
Sep
Pennsylvania COVID-19 Restaurant Restrictions Remain Fluid Norris McLaughlin P.A.
17
Sep
A NanoBCA Retrospective — A Conversation with Vincent Caprio [PODCAST] Bergeson & Campbell, P.C.
16
Sep
Bioethics in a Pandemic: Vaccine Research and Clinical Trials Mintz
16
Sep
White House Directs HHS to Model "Most-Favored-Nation" Price Caps for Part B and D Drugs McDermott Will & Emery
16
Sep
Latest Update on FDA’s Software Pre-Cert Pilot Program Sheppard, Mullin, Richter & Hampton LLP
16
Sep
Employee’s Request To Revise Drug Policy To Address CBD Use Was Not A Reasonable Accommodation Jackson Lewis P.C.
15
Sep
Time to Act Against Chinese Parallel Import of Foreign Cosmetic Products Squire Patton Boggs (US) LLP
15
Sep
Trump Signs Executive Orders Aimed at Tying Domestic Drug Prices to Foreign Prices Mintz
15
Sep
When to Give Legal Rights to AIs? When They Can Dream Womble Bond Dickinson (US) LLP
15
Sep
Trump Signs Executive Orders Aimed at Tying Domestic Drug Prices to Foreign Prices Mintz
14
Sep
Trade Secret Protection & the COVID-19 Cure: Observations on Federal Policy-Making & Potential Impact on Biomedical Advances Sheppard, Mullin, Richter & Hampton LLP
14
Sep
UK End of Transition – Moves to Provide Clarity for Industry Squire Patton Boggs (US) LLP
14
Sep
FSIS Proposes to Expand Eligibility for Generic Label Approval and to Discontinue FSIS Evaluation of Voluntarily Submitted Labels That are Eligible for Generic Approval Keller and Heckman LLP
11
Sep
China Continues Efforts to Ban and Limit Use of Plastic Products Keller and Heckman LLP
11
Sep
What are the Requirements for Using Aluminum Foil as a Functional Barrier? Keller and Heckman LLP
11
Sep
COVID-19 Weekly Newsletter: Pharma Companies Sign Vaccine Pledge, Relief Package Stalls Faegre Drinker
11
Sep
California Supreme Court Clarifies Bounds of Legitimate Competition Under Tort and Antitrust Law The National Law Review's Guest Contributors

Pages

Advertisement
Advertisement

TRENDING LEGAL ANALYSIS

Upcoming Legal Education Events

Tuesday, December 8, 2020
Wednesday, December 9, 2020
Wednesday, December 9, 2020
Wednesday, December 9, 2020
Thursday, December 10, 2020
Thursday, December 10, 2020
Thursday, December 17, 2020
Advertisement